GW Pharmaceuticals PLC (GWPH) Dips More Than Broader Markets: What You Should Know

In the latest trading session, GW Pharmaceuticals PLC (GWPH) closed at $143.95, marking a -1.32% move from the previous day. This move lagged the S&P 500's daily loss of 0.35%. Elsewhere, the Dow lost 0.4%, while the tech-heavy Nasdaq lost 0.39%.

Prior to today's trading, shares of the company had gained 7.46% over the past month. This has outpaced the Medical sector's gain of 3.02% and the S&P 500's gain of 4.48% in that time.

Wall Street will be looking for positivity from GWPH as it approaches its next earnings report date. This is expected to be February 26, 2019. In that report, analysts expect GWPH to post earnings of -$2.97 per share. This would mark a year-over-year decline of 22.22%. Meanwhile, our latest consensus estimate is calling for revenue of $7.10 million, down 8.15% from the prior-year quarter.

GWPH's full-year Zacks Consensus Estimates are calling for earnings of -$10.18 per share and revenue of $87.55 million. These results would represent year-over-year changes of +3.6% and +416.31%, respectively.

Investors should also note any recent changes to analyst estimates for GWPH. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. GWPH is currently a Zacks Rank #2 (Buy).

The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 88, putting it in the top 35% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
GW Pharmaceuticals PLC (GWPH) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.